Sierra Oncology Inc. Shares Close the Week 21.5% Higher - Weekly Wrap

The company saw its shares close the week 21.5% higher than last week, with trading volume higher than its 30 day average.

Mar 19, 2021 by Kwhen Finance Editors

Sierra Oncology Inc. Shares Close the Week 21.5% Higher - Weekly Wrap
Sierra Oncology Inc. shares closed this week 21.5% higher than it did at the end of last week. The stock is currently up 25.5% year-to-date, up 114.4% over the past 12 months, and up 194.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%.

Trading Activity

  • Shares traded as high as $20.40 and as low as $16.42 this week.
  • Shares closed 1% below its 52-week high and 1e+2% above its 52-week low.
  • Trading volume this week was 8.9% higher than the 10-day average and 40.3% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.4.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Sierra Oncology Inc.-0.325.5114.4-1.1133.3
Dow Jones Industrial Average-0.87.173.3-1.283.8
S&P 500 Index-0.24.573.0-1.781.5
Health Care0.51.551.4-4.061.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 164.5%
  • The company's stock price performance over the past 12 months beats the peer average by 606.0%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Sierra Oncology Inc.SRRA025.5114.4-1.1133.3
Peer AvgN/A-2.29.616.2-20.536.8
Omeros CorporationOMER-8.939.473.6-20.6104.6
Odonate Therapeutics Inc.ODT0-0.9-8.8-61.542.5

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: